scholarly journals Protective role of intravesical BCG in COVID-19 severity

BMC Urology ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Héctor Gallegos ◽  
Pablo A. Rojas ◽  
Francisca Sepúlveda ◽  
Álvaro Zúñiga ◽  
Ignacio F. San Francisco

Abstract Objectives To establish the role of BCG instillations in the incidence and mortality of COVID-19. Patients and methods NMIBC patients in instillations with BCG (induction or maintenance) during 2019/2020 were included, establishing a COVID-19 group (with a diagnosis according to the national registry) and a control group (NO-COVID). The cumulative incidence (cases/total patients) and the case fatality rate (deaths/cases) were established, and compared with the national statistics for the same age group. T-test was used for continuous variables and Fisher's exact test for categorical variables. Results 175 patients were included. Eleven patients presented CIS (11/175, 6.3%), 84/175 (48.0%) Ta and 68/175 (38.9%) T1. Average number of instillations = 13.25 ± 7.4. One hundred sixty-seven patients (95.4%) had complete induction. Forty-three patients (cumulative incidence 24.6%) were diagnosed with COVID-19. There is no difference between COVID-19 and NO-COVID group in age, gender or proportion of maintenance completed. COVID-19 group fatality rate = 1/43 (2.3%). Accumulated Chilean incidence 70–79 years = 6.3%. Chilean fatality rate 70–79 years = 14%. Conclusions According to our results, patients with NMIBC submitted to instillations with BCG have a lower case-fatality rate than the national registry of patients between 70 and 79 years (2.3% vs. 14%, respectively). Intravesical BCG could decrease the mortality due to COVID-19, so instillation schemes should not be suspended in a pandemic.

Neurology ◽  
2020 ◽  
Vol 95 (10) ◽  
pp. e1417-e1425 ◽  
Author(s):  
Pablo Cabezudo-García ◽  
Nicolás Lundahl Ciano-Petersen ◽  
Natalia Mena-Vázquez ◽  
Gracia Pons-Pons ◽  
María Victoria Castro-Sánchez ◽  
...  

ObjectiveThis article estimates the incidence and fatality of coronavirus disease 2019 (COVID-19) and identifies potential risk factors for fatality in patients with active epilepsy.MethodsThis is a cross-sectional observational study of patients with active epilepsy and COVID-19. A control group was used to compare the cumulative incidence and case-fatality rate (CFR). The main outcomes of the study were cumulative incidence, defined as number of patients with active epilepsy and COVID-19 admitted to an emergency department divided by the total number of patients with epilepsy at risk, and CFR based on the number of deaths during the enrollment period. Multiple logistic regression analysis was performed to investigate risk factors for fatality in patients with active epilepsy.ResultsOf the 1,537 patients who fulfilled the inclusion criteria, 21 (1.3%) had active epilepsy. The cumulative incidence (95% confidence interval [CI]) of COVID-19 in patients with epilepsy was higher (1.2% [0.6–2.4]) compared to the population without epilepsy (0.5% [0.5–0.5]). In reverse transcription PCR–positive patients, there were no significant differences in CFR in patients with active epilepsy compared to patients without epilepsy (33.3% vs 8.3%; p = 0.266). Of the 21 patients with active epilepsy, 5 (23%) died. In multivariate analysis, the factor associated with fatality in patients with active epilepsy was hypertension (odds ratio [OR] 2.8 [95% CI 1.3–21.6]). In another model, age (OR 1.0 [95% CI 1.0–1.1]) and epilepsy (OR 5.1 [95% CI 1.3–24.0]) were associated with fatality during hospitalization.ConclusionCOVID-19 cumulative incidence was higher in patients with active epilepsy. Epilepsy was associated with fatality during hospitalization. Hypertension was associated with fatality in patients with epilepsy.


2020 ◽  
pp. 147332502097329
Author(s):  
Hamed Mortazavi

As the number of patients infected with the 2019 novel coronavirus disease (nCOVID-19) increases, the number of deaths has also been increasing. According to World Health Organization (WHO), as of 4 October 2020, 34,804,348 cases had tested positive for nCOVID-19 globally, which among them, 1,030,738 confirmed deaths had occurred, equivalent to a case-fatality rate of 2.96%. However, in comparison with global statistics, the incidence and mortality of the nCOVID-19 infection are higher in Iran. As reported by the National Committee on COVID-19 Epidemiology of Ministry of Health of Iran, the total number of patients with confirmed COVID-19 infection has reached 468,119, of which 26,746 have died, equivalent to a case-fatality rate of 5.71%. Currently, there is solid evidence that older adults are at a higher risk of severe disease following infection from COVID-19.


2021 ◽  
Vol 9 (11) ◽  
pp. 2286
Author(s):  
Sara De Miguel ◽  
Pello Latasa ◽  
José Yuste ◽  
Luis García ◽  
María Ordobás ◽  
...  

The aim of this study was to investigate the serotype-associated fatality rate in cases of invasive pneumococcal disease (IPD) in the Spanish region of Madrid between 2007 and 2020. Serotyping was performed by Pneumotest Latex and the Quellung reaction using commercial antisera. Case-fatality rate was estimated as the ratio between the number of deaths at hospital discharge and the number of cases attributable to each serotype. To evaluate the association measures, the odds ratios with a 95% confidence interval were calculated. Twenty five pneumococcal serotypes were associated to mortality and comprised 87.8% of the total number of isolates characterized. Serotypes 8, 3, 19A, 1, 7F, 22F, 12F, and 11A were the most prevalent (≥3% each). Serotypes 31, 11A, and 19F were significantly associated to high case-fatality rates (>20% each). The lower significantly associated case-fatality rate (<10% each) was found in serotypes 5, 1, 12B, 7F, 12F, 8, 33, and 10A. The serotypes with higher mortality levels (≥0.04 per 100,000 population) were 11A (fatality 24.0%), 3 (fatality 18.7%), 19A (fatality 12.5%), and 8 (fatality 7.2%). Serotype 3 was worrisome because it is associated with important fatality levels combined with very high incidence and mortality rates. Serotype 11A also showed a high fatality with marked incidence and mortality levels. Some few frequent serotypes as 31, 19F, and 15A despite its high fatality had low levels of mortality. By contrast other serotypes as 8 showing low fatality had high mortality ranges because it shows a wide extended distribution. Finally, common serotypes, such as 1 and 5, presented small mortality length, due to their low case-fatality rates.


Author(s):  
Vanessa Vasquez-Apestegui ◽  
Enrique Parras-Garrido ◽  
Vilma Tapia ◽  
Valeria M. Paz-Aparicio ◽  
Jhojan P. Rojas ◽  
...  

Abstract Background Corona virus disease (COVID-19) originated in China in December 2019. Thereafter, a global logarithmic expansion of the cases has occurred. Some countries have a higher rate of infections despite of early implementation of quarantine. Air pollution could be related to the high susceptibility to SARS-CoV-2 and the associated case-fatality rates (deaths/cases*100). Lima, Peru has the second highest incidence of COVID-19 in Latin America and it is also one of the cities with highest levels of air pollution in the Region. Methods This study investigated the association of the levels of PM2.5 exposure in the previous years (2010–2016) in 24 districts of Lima with the cases, deaths and case-fatality rates of COVID-19. Results Until June 12, 2020, there were 6,308 deaths and 220,749 SARS-CoV-2 positive cases in Peru. In Lima, the total number of COVID-19 deaths in all metropolitan areas was 2,382. The case-fatality rate at the national level was 2.58% and 1.93% in Lima. Higher PM2.5 levels are associated with higher number of cases and deaths of COVID-19. The case-fatality rate (Deaths/cases*100) did not increase with the increase in PM2.5 levels. A higher number of food markets was associated with higher incidence and mortality of COVID-19 (p < 0.01 for both); these associations persisted when cases (r = 0.49; p < 0.01) and deaths (r = 0.58; p < 0.01) were adjusted by the population density. The association of PM2.5 with cases of COVID-19 was maintained after controlling analysis by age, sex and number of food markers. Conclusions the higher rates of COVID-19 in Metropolitan Lima is attributable, among others, to the increased PM2.5 exposure in the previous years after adjusting for age, sex and number of food markets. Reduction of air pollution since a long term perspective, and social distancing are needed to prevent spreads of virus outbreak.


2020 ◽  
Vol 10 (1) ◽  
pp. 1792620 ◽  
Author(s):  
Mohammad M. Hassan ◽  
Mohamed E. El Zowalaty ◽  
Shahneaz A. Khan ◽  
Ariful Islam ◽  
Md. Raihan K. Nayem ◽  
...  

2019 ◽  
Author(s):  
Jia Bainga Kangbai ◽  
Christian Heumann ◽  
Michael Hoelscher ◽  
Foday Sahr ◽  
Guenter Froeschl

Abstract Background The 2013 – 2016 West Africa Ebola Virus Disease (EVD) outbreak recorded the highest incidence and mortality since the discovery of the virus in Zaire in 1976. Studies relating to previous outbreaks usually involved small sample sizes. In this study we are set to identify those sociodemographic and clinical features that predict in-facility mortality among EVD patients using a large sample size. Methods We analysed the anonymized medical records of 938 laboratory-confirmed EVD patients 15 years old and above that received treatment at the 34 Military Hospital and the Police Training School EVD Treatment Centers in Sierra Leone in the period June 2014 to April 2015. We used both univariable and multivariable logistic regression to determine the predictors for in-facility mortality of these patients based on their sociodemographic and clinical characteristics. Results The median age of the EVD cases was 33 years (interquartile range = 25 to 40 years). The majority of the EVD cases were male (59.0%) and had secondary level education (79.3%). A low overall in-facility case fatality rate of 26.4% was shown. The associations between case fatality rates and EVD patients who reported fever, abdominal pain, cough, diarrhoea, vomiting, fatigue, haemorrhage, dysphagia, conjunctival injection, dyspnoea, and skin rash at the time of admission were statistically significant (p < 0.05). Our preferred model with age group of EVD patients and the presence of the symptoms diarrhoea, vomiting, fatigue, dysphagia, conjunctival injection, dyspnoea and muscle pain produced a receiver operating characteristic (ROC) curve with an AUC (area under the curve) value of 0.94. Conclusions The age of EVD patients, as well those patients who reported vomiting, diarrhoea, fatigue, dysphagia, conjunctival injection, dyspnoea and muscle pain have increased odds of dying during treatment and hence will require prompt and intensive treatment at the time of admission. We argue that the high proportion of individuals with higher educational levels may have been a critical determinant for the low case fatality rate.


Author(s):  
Paolo Pasquariello ◽  
Saverio Stranges

There is much discussion among clinicians, epidemiologists, and public health experts about why case fatality rate from COVID-19 in Italy (at 13.3% as of April 20, 2020, versus a global case fatality rate of 6.9%) is considerably higher than estimates from other countries (especially China, South Korea, and Germany). In this article, we propose several potential explanations for these differences. We suggest that Italy&rsquo;s overall and relative case fatality rate, as reported by public health authorities, is likely to be inflated by such factors as heterogeneous reporting of coronavirus-related fatalities across countries and the iceberg effect of under-testing, yielding a distorted view of the global severity of the COVID-19 pandemic. We also acknowledge that deaths from COVID-19 in Italy are still likely to be higher than in other equally affected nations due to its unique demographic and socio-economic profile. Lastly, we discuss the important role of the stress imparted by the epidemic on the Italian healthcare system, which weakened its capacity to adequately respond to the sudden influx of COVID-19 patients in the most affected areas of the country, especially in the Lombardy region.


2020 ◽  
Author(s):  
Paolo Di Girolamo

Abstract The Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2), which exploded in Wuhan (Hebei Region, China) in late 2019, has recently spread around the World, causing pandemic effects on humans. Italy, and especially its Northern regions around the Po Valley, has been facing severe effects in terms of infected individuals and casualties (more than 31.000 deaths and 255.000 infected people by mid-May 2020). While the spread and effective impact of the virus is primarily related to the life styles and social habits of the different human communities, environmental and meteorological factors also play a role. Among these, pollution from PM2.5/PM10 particles, which may directly impact on the human respiratory system or act as virus carrier, thus behaving as potential amplifying factors in the pandemic spread of SARS-CoV-2. Enhanced levels of PM2.5/PM10 particles in Northern Italy were observed over the two month period preceding the virus pandemic spread. Threshold levels for PM10 (<50 µg/m³) were exceeded on 20-35 days over the period January-February 2020 in many areas in the Po Valley, where major effects in terms of infections and casualties occurred, with levels in excess of 80 µg/m³ occasionally observed in the 1-3 weeks preceding the contagious activation around February 25th. Threshold values for PM2.5 indicted in WHO air quality guidelines (<25 µg/m³) were exceeded on more than 40 days over the period January-February 2020 in large portions of the Po Valley, with levels up to 70 µg/m³ observed in the weeks preceding the contagious activation. The evolution of particle matter concentration levels throughout the month of February 2020 was carefully monitored and results are reported in the paper.In this paper PM10 particle measurements are compared with epidemiologic parameters data. Specifically, a statistical analysis is carried out to correlate the infection rate, or incidence of the pathology, the mortality rate and the case fatality rate with PM concentration levels. The study considers epidemiologic data for all 110 Italian Provinces, as reported by the Italian Statistics Institute (ISTAT, 2020), over the period 20 February-31 March 2020. Corresponding PM10 concentration levels were collected from the network of air quality monitoring stations run by different Regional and Provincial Environment Agencies, covering the period 15-26 February 2020. The case fatality rate is found to be highly correlated to the average PM10 concentration, with a correlation coefficient of 0.89 and a slope of the regression line of (6.7±0.3)×10-3 m³/µg, which implies a doubling (from 3 to 6 %) of the mortality rate of infected patients for an average PM10 concentration increase from 22 to 27 μg/m³. Infection and mortality rates are also found to be correlated with PM10 concentration levels, with correlation coefficients being 0.82 and 0.80, respectively, and the slopes of the regression lines indicating a doubling (from 1 to 2 ‰) of the infection rate and a tripling (from 0.1 to 0.3 ‰) of the mortality rate for an average PM10 concentration increase from 25 to 29 μg/m³. Epidemiologic parameters data were also compared with population density data, but no clear evidence of a mutual correlation between these quantities was found. Considerations on the exhaled particles' sizes and concentrations, their residence times, transported viral dose and minimum infective dose, in combination with PM2.5/PM10 pollution measurements and an analytical microphysical model, allowed assessing the potential role of airborne transmission through virus-transmitting PM particles, in addition to droplet transmission, in conveying SARS-CoV-2 in the human respiratory system.


2015 ◽  
Vol 24 (4) ◽  
pp. 507-514 ◽  
Author(s):  
Simona Valean ◽  
Monica Acalovschi ◽  
Mircea Diculescu ◽  
Mircea Manuc ◽  
Adrian Goldis ◽  
...  

We aimed to compare the difference in case fatality rate between more developed and very high Human Development Index (HDI) regions, less developed and low HDI regions, and Romania. The incidence and mortality rates for digestive cancers were obtained from the IARC/WHO 2012 database. World mean mortality-to-incidence ratios registered the highest values in pancreatic cancer (0.97/0.94), and liver cancer (0.93/0.96) in males/females, respectively. The lowest values were recorded in colorectal cancer (0.48 in both sexes). Mortality-to-incidence ratios were generally higher in less developed areas, low HDI populations, and in Romania. The difference in case fatality rate between different areas showed higher variations for colorectal, gastric and gallbladder cancers, and smaller variations for esophageal, liver, and pancreatic cancers. In summary, mortality-to-incidence ratios of digestive cancers were high in 2012; higher values were registered in less developed and low HDI regions, and in Romania. Mortality-to-incidence ratios were similar in both sexes, even though the incidence was generally higher in men. Digestive cancer mortality variation suggests the necessity of finding better strategies for prevention, early diagnosis and treatment of digestive cancers. Abbreviations: ASRWs: age-standardized rate (World Standard Population) per 100,000 population; CRC: colorectal cancer; GC: gastric cancer; HDI: Human Development Index; HCC: hepatocellular carcinoma; IARC: International


2020 ◽  
Vol 105 (12) ◽  
pp. 1180-1185 ◽  
Author(s):  
Shamez N Ladhani ◽  
Zahin Amin-Chowdhury ◽  
Hannah G Davies ◽  
Felicity Aiano ◽  
Iain Hayden ◽  
...  

ObjectivesTo assess disease trends, testing practices, community surveillance, case-fatality and excess deaths in children as compared with adults during the first pandemic peak in England.SettingEngland.ParticipantsChildren with COVID-19 between January and May 2020.Main outcome measuresTrends in confirmed COVID-19 cases, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positivity rates in children compared with adults; community prevalence of SARS-CoV-2 in children with acute respiratory infection (ARI) compared with adults, case-fatality rate in children with confirmed COVID-19 and excess childhood deaths compared with the previous 5 years.ResultsChildren represented 1.1% (1,408/129,704) of SARS-CoV-2 positive cases between 16 January 2020 and 3 May 2020. In total, 540 305 people were tested for SARS-COV-2 and 129,704 (24.0%) were positive. In children aged <16 years, 35,200 tests were performed and 1408 (4.0%) were positive for SARS-CoV-2, compared to 19.1%–34.9% adults. Childhood cases increased from mid-March and peaked on 11 April before declining. Among 2,961 individuals presenting with ARI in primary care, 351 were children and 10 (2.8%) were positive compared with 9.3%–45.5% in adults. Eight children died and four (case-fatality rate, 0.3%; 95% CI 0.07% to 0.7%) were due to COVID-19. We found no evidence of excess mortality in children.ConclusionsChildren accounted for a very small proportion of confirmed cases despite the large numbers of children tested. SARS-CoV-2 positivity was low even in children with ARI. Our findings provide further evidence against the role of children in infection and transmission of SARS-CoV-2.


Sign in / Sign up

Export Citation Format

Share Document